JoEllen Zembruski-Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Patritumab deruxtecan treatment did not improve suvival end points versus those treated with chemotherapy in EGFR+ ...

Pembrolizumab with sacituzumab govitecan instead of chemotherapy led to improved progression-free survival in PD-L1-postive ...